Anti α1-3Gal antibodies and Gal content in gut microbiota in immune disorders and multiple sclerosis - Centre de Recherche en Transplantation et Immunologie
Article Dans Une Revue Clinical Immunology Année : 2022

Anti α1-3Gal antibodies and Gal content in gut microbiota in immune disorders and multiple sclerosis

Résumé

Recent observations suggest that Gal antigen content in gut microbiota and anti-Gal antibody response may influence inflammation in immune related disorders. In this review we summarized the current knowledge on antibody response to the Gal epitope in various immune disorders. We discuss the origin of Gal antigen associated to gut microbiota. In multiple sclerosis, the possible mechanisms by which the altered microbiota and/or circulating anti-Gal level could affect the immune response in this disease are presented.
Fichier principal
Vignette du fichier
S1521661621000309.pdf (1.14 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04698738 , version 1 (13-11-2024)

Licence

Identifiants

Citer

Léo Boussamet, Emmanuel Montassier, Jean-Paul Soulillou, Laureline Berthelot. Anti α1-3Gal antibodies and Gal content in gut microbiota in immune disorders and multiple sclerosis. Clinical Immunology, 2022, 235, pp.108693. ⟨10.1016/j.clim.2021.108693⟩. ⟨hal-04698738⟩
3 Consultations
0 Téléchargements

Altmetric

Partager

More